Regarding mechanism, MFAP2 was mainly involved in ATP formation; TP53 mutation interacted with MFAP2 to participate in the hepatocellular carcinoma cell occurrence, and MFAP2 knockdown inhibited hepatocellular carcinoma cell proliferation (21). This evidence concerns the gene TP53 and hepatocellular carcinoma.